Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
28,037 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Legends captivate us, but their financial legacies teach us more. This guide turns the mystique of a modern icon into...
A single online moment can spark real-world spending. This article uses the Selena Gomez Says “Lol” moment to explore...
A budget standoff at U.S. airports can ripple into your wallet long after you land. This article breaks down what hap...
As inflation cools and markets wobble, a quartet of monthly-pay ETFs now offers 6% to 9% yields. This article explain...
Deregulation can tilt the odds for certain industries and investment themes. This guide explains how to spot opportun...
NVIDIA leads the AI chip market with strong cash returns, while Intel pursues a turnaround with a cautious growth pro...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
A disciplined $500 monthly investment into a semiconductor-focused ETF since 2016 would have climbed to roughly half ...
This week, plug power stock rocketed about 20% as earnings and feasibility signals fed optimism about hydrogen adopti...
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
SpaceX is trading far above its IPO price. This article explains what that gain means for early investors, what could...